CRVS holders · GOLDMAN SACHS GROUP INC 13F · CRVS stock

GOLDMAN SACHS GROUP INC Corvus Pharmaceuticals Inc (CRVS) 13F holding

GOLDMAN SACHS GROUP INC reported 1,540,809 CRVS shares valued at $22.5M as of 2026-03-31. Share lines from that 13F summed, options excluded; value is the 13F-reported market value in US dollars, as reported on Form 13F, not a live feed.

This is the newest CRVS 13F on file for this filer CIK, and it is older than the quarter ended 2026-06-30. It is kept for history and left out of the CRVS holders table.

Not investment advice. Holdings as reported on Form 13F; EDGAR is the official record.